Literature DB >> 2173396

Comparative analysis of human papillomavirus detection by polymerase chain reaction and Virapap/Viratype kits.

G C Burmer1, J D Parker, J Bates, K East, B G Kulander.   

Abstract

Cervical samples from 270 women referred by area physicians were analyzed for the presence of human papillomavirus (HPV) types 6, 11, 16, and 18 by the polymerase chain reaction (PCR) followed by Southern hybridization. Samples from 154 patients were concurrently analyzed by a commercial filter hybridization technique (Virapap and Viratype Kits, Life Technologies, Bethesda Research Labs, Gaithersburg, MD). The sensitivity of the Southern blot procedure combined with PCR was significantly higher than that of the Virapap and Viratype methods. HPV was detected in 67% of women who had positive results for dysplasia by PCR and in 47% by the Virapap method. HPV types 16/18 were found more commonly than types 6/11 in every diagnostic category. More than one HPV type was detected in 12% of HPV-positive patients. The prevalence of HPV in cytologically negative or indefinite patients as measured by PCR was 22% and 40%; in contrast, by the Virapap method, these values were 7% and 10%. These results demonstrate that PCR combined with Southern hybridization provides a higher level of sensitivity than methods that use hybridization without amplification of HPV DNA and also show that the prevalence of HPV is highest in cytologically positive smears.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2173396     DOI: 10.1093/ajcp/94.5.554

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  10 in total

1.  Comparison of ViraPap, Southern hybridization, and polymerase chain reaction methods for human papillomavirus identification in an epidemiological investigation of cervical cancer.

Authors:  E Guerrero; R W Daniel; F X Bosch; X Castellsagué; N Muñoz; M Gili; P Viladiu; C Navarro; M L Zubiri; N Ascunce
Journal:  J Clin Microbiol       Date:  1992-11       Impact factor: 5.948

Review 2.  Use of the polymerase chain reaction to study the relationship between human papillomavirus infections and cervical cancer.

Authors:  W J Melchers; H C Claas; W G Quint
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-09       Impact factor: 3.267

3.  Low false-negative rate of PCR analysis for detecting human papillomavirus-related cervical lesions.

Authors:  P Zazove; B D Reed; L Gregoire; A Ferenczy; D W Gorenflo; W D Lancaster
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

4.  Detection and typing of human papillomavirus infection affecting the cervix, vagina and vulva. Comparison of DNA hybridization with cytological, colposcopic and histological examinations.

Authors:  S Vuopala; R Pöllänen; A Kauppila; V P Lehto
Journal:  Arch Gynecol Obstet       Date:  1993       Impact factor: 2.344

5.  Polymerase chain reaction detection of human papillomavirus: quantitation may improve clinical utility.

Authors:  E A Morrison; G L Goldberg; A S Kadish; R D Burk
Journal:  J Clin Microbiol       Date:  1992-10       Impact factor: 5.948

6.  Comparison of Virapap filter hybridization with polymerase chain reaction and Southern blot hybridization methods for detection of human papillomavirus in tonsillar and pharyngeal cancers.

Authors:  S Watanabe; H Ogura; K Fukushima; Y Yabe
Journal:  Eur Arch Otorhinolaryngol       Date:  1993       Impact factor: 2.503

7.  Carcinomas of Bartholin's gland. Histogenesis and the etiological role of human papillomavirus.

Authors:  J C Felix; R J Cote; E E Kramer; P Saigo; G H Goldman
Journal:  Am J Pathol       Date:  1993-03       Impact factor: 4.307

8.  Comparison of dot filter hybridization, Southern transfer hybridization, and polymerase chain reaction amplification for diagnosis of anal human papillomavirus infection.

Authors:  J M Kuypers; C W Critchlow; P E Gravitt; D A Vernon; J B Sayer; M M Manos; N B Kiviat
Journal:  J Clin Microbiol       Date:  1993-04       Impact factor: 5.948

9.  Detection of human papillomavirus type 16 in sexual partners of patients having cervical cancer by polymerase chain reaction.

Authors:  A Nakazawa; M Inoue; M Fujita; O Tanizawa; A Hakura
Journal:  Jpn J Cancer Res       Date:  1991-11

10.  Evaluation of two commercially available DNA tests for detection of human papillomavirus.

Authors:  D C Halstead; S L Pfleger; W Dupree
Journal:  Infect Dis Obstet Gynecol       Date:  1995
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.